Sara Pratesi

1.0k total citations
40 papers, 806 citations indexed

About

Sara Pratesi is a scholar working on Immunology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sara Pratesi has authored 40 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 9 papers in Pathology and Forensic Medicine and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sara Pratesi's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Drug-Induced Adverse Reactions (7 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). Sara Pratesi is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Drug-Induced Adverse Reactions (7 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). Sara Pratesi collaborates with scholars based in Italy, United States and Netherlands. Sara Pratesi's co-authors include Enrico Maggi, Francesca Nencini, Alessandra Vultaggio, Andrea Matucci, Sergio Romagnani, Giulia Petroni, Paola Parronchi, Oliviero Rossi, Alberto Chiarugi and Daniele Cammelli and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Journal of Allergy and Clinical Immunology.

In The Last Decade

Sara Pratesi

40 papers receiving 789 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Pratesi Italy 17 351 191 188 148 142 40 806
RP Phipps United States 10 204 0.6× 35 0.2× 93 0.5× 88 0.6× 108 0.8× 14 585
M.J. Garlepp Australia 18 397 1.1× 80 0.4× 41 0.2× 169 1.1× 171 1.2× 38 1.2k
Edith Oregon‐Romero Mexico 16 339 1.0× 81 0.4× 38 0.2× 88 0.6× 158 1.1× 51 788
S. Yamamoto Japan 17 325 0.9× 67 0.4× 32 0.2× 148 1.0× 172 1.2× 38 766
Chihiro Ishioka Japan 16 267 0.8× 53 0.3× 22 0.1× 202 1.4× 150 1.1× 29 771
Lynda Kabbash United States 7 291 0.8× 39 0.2× 56 0.3× 88 0.6× 144 1.0× 9 690
Roly Foulkes United Kingdom 14 331 0.9× 107 0.6× 20 0.1× 118 0.8× 167 1.2× 30 898
Vishala Chindalore United States 10 420 1.2× 234 1.2× 42 0.2× 90 0.6× 167 1.2× 17 835
Lesley Mason United Kingdom 14 427 1.2× 270 1.4× 45 0.2× 40 0.3× 149 1.0× 20 896
Yoony Y. J. Gent Netherlands 12 378 1.1× 65 0.3× 15 0.1× 104 0.7× 220 1.5× 18 925

Countries citing papers authored by Sara Pratesi

Since Specialization
Citations

This map shows the geographic impact of Sara Pratesi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Pratesi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Pratesi more than expected).

Fields of papers citing papers by Sara Pratesi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Pratesi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Pratesi. The network helps show where Sara Pratesi may publish in the future.

Co-authorship network of co-authors of Sara Pratesi

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Pratesi. A scholar is included among the top collaborators of Sara Pratesi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Pratesi. Sara Pratesi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peruzzi, Benedetta, Tiziana Biagioli, Sara Pratesi, et al.. (2024). HPLC and flow cytometry combined approach for HbF analysis in fetomaternal haemorrhage evaluation. Practical Laboratory Medicine. 40. e00401–e00401. 1 indexed citations
2.
Scaletti, Cristina, et al.. (2024). The B-cells paradigm in systemic sclerosis: an update on pathophysiology and B-cell-targeted therapies. Clinical & Experimental Immunology. 219(1). 2 indexed citations
3.
Bella, Chiara Della, Alberto Corrà, Elisabetta Mantengoli, et al.. (2023). Skin IL-17A and IFN-γ Production Correlate with Disease Severity in Patients with Psoriasis and Streptococcal Infection. Journal of Investigative Dermatology. 143(6). 925–932. 10 indexed citations
4.
Bella, Chiara Della, Antonio Antico, Maria Piera Panozzo, et al.. (2022). Gastric Th17 Cells Specific for H+/K+-ATPase and Serum IL-17 Signature in Gastric Autoimmunity. Frontiers in Immunology. 13. 952674–952674. 17 indexed citations
5.
Bendinelli, Benedetta, Giovanna Masala, Chiara Della Bella, et al.. (2022). Adipocytokine plasma level changes in a 24-month dietary and physical activity randomised intervention trial in postmenopausal women. European Journal of Nutrition. 62(3). 1185–1194. 4 indexed citations
6.
7.
Pratesi, Sara, Francesca Nencini, Daniele Cammelli, et al.. (2019). T Cell Response to Infliximab in Exposed Patients: A Longitudinal Analysis. Frontiers in Immunology. 9. 3113–3113. 12 indexed citations
8.
Matucci, Andrea, Francesco Liotta, Emanuele Vivarelli, et al.. (2018). Efficacy and Safety of Mepolizumab (Anti-Interleukin-5) Treatment in Gleich’s Syndrome. Frontiers in Immunology. 9. 1198–1198. 13 indexed citations
9.
Nencini, Francesca, Alessandra Vultaggio, Sara Pratesi, et al.. (2018). The Kinetics of Antidrug Antibodies, Drug Levels, and Clinical Outcomes in Infliximab-Exposed Patients with Immune-Mediated Disorders. The Journal of Allergy and Clinical Immunology In Practice. 6(6). 2065–2072.e2. 18 indexed citations
10.
Felici, Roberta, Daniela Buonvicino, Mirko Muzzi, et al.. (2017). Post onset, oral rapamycin treatment delays development of mitochondrial encephalopathy only at supramaximal doses. Neuropharmacology. 117. 74–84. 22 indexed citations
11.
Manetti, Mirko, Sara Pratesi, Eloisa Romano, et al.. (2017). Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis. PLoS ONE. 12(8). e0183102–e0183102. 34 indexed citations
12.
Pratesi, Sara, Francesca Nencini, Lucia Filì, et al.. (2016). Dermatophagoides pteronyssinus group 2 allergen bound to 8-OH modified adenine reduces the Th2-mediated airway inflammation without inducing a Th17 response and autoimmunity. Molecular Immunology. 77. 60–70. 4 indexed citations
13.
Vultaggio, Alessandra, Giulia Petroni, Sara Pratesi, et al.. (2016). Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions. Clinical & Experimental Immunology. 186(3). 364–372. 32 indexed citations
14.
Vultaggio, Alessandra, Giulia Petroni, Sara Pratesi, et al.. (2016). How the immune system responds to therapeutic biological agents. Journal of International Medical Research. 44(1_suppl). 38–42. 13 indexed citations
15.
Felici, Roberta, Andrea Lapucci, Leonardo Cavone, et al.. (2015). Pharmacological NAD-Boosting Strategies Improve Mitochondrial Homeostasis in Human Complex I–Mutant Fibroblasts. Molecular Pharmacology. 87(6). 965–971. 22 indexed citations
16.
Vultaggio, Alessandra, Francesca Nencini, Sara Pratesi, et al.. (2014). Manifestations of Antidrug Antibodies Response: Hypersensitivity and Infusion Reactions. Journal of Interferon & Cytokine Research. 34(12). 946–952. 32 indexed citations
17.
Filì, Lucia, Alessandra Vultaggio, Cinzia Manuelli, et al.. (2013). A novel allergen-adjuvant conjugate suitable for specific immunotherapy of respiratory allergy. Journal of Allergy and Clinical Immunology. 132(1). 84–92.e6. 13 indexed citations
18.
Vultaggio, Alessandra, Andrea Matucci, Francesca Nencini, et al.. (2012). Drug-Specific Th2 Cells and IgE Antibodies in a Patient with Anaphylaxis to Rituximab. International Archives of Allergy and Immunology. 159(3). 321–326. 53 indexed citations
19.
Vultaggio, Alessandra, Andrea Matucci, Francesca Nencini, et al.. (2009). Anti‐infliximab IgE and non‐IgE antibodies and induction of infusion‐related severe anaphylactic reactions. Allergy. 65(5). 657–661. 183 indexed citations
20.
Pellegrini, Sandra, B. Fuzzi, Sara Pratesi, et al.. (1995). Physiology: In-vivo studies on ovarian insulin-like growth factor I concentrations in human preovulatory follicles and human ovarian circulation. Human Reproduction. 10(6). 1341–1345. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by RP Phipps Breakdown of academic impact, for papers by M.J. Garlepp Breakdown of academic impact, for papers by Edith Oregon‐Romero Breakdown of academic impact, for papers by S. Yamamoto Breakdown of academic impact, for papers by Chihiro Ishioka Breakdown of academic impact, for papers by Lynda Kabbash Breakdown of academic impact, for papers by Roly Foulkes Breakdown of academic impact, for papers by Vishala Chindalore Breakdown of academic impact, for papers by Lesley Mason Breakdown of academic impact, for papers by Yoony Y. J. Gent
Rankless by CCL
2026